| 12384875 |
High-performance ladder polymers for membrane gas separation |
Holden Wan Hong Lai, Jun Myun Ahn, Zachary Smith, Francesco Maria Benedetti |
2025-08-12 |
|
| 11850557 |
Intrinsically microporous ladder-type Tröger's base polymers |
Xiaohua Ma, Ingo Pinnau, Holden W. H. Lai |
2023-12-26 |
|
| 11786607 |
RNA formulations |
Stephen Hoge, Joseph Schariter, Charles Bowerman, Michael H. Smith |
2023-10-17 |
|
| 11003720 |
Relevance-ordered message search |
Tian Wang, Juan Manual Caicedo Carvajal |
2021-05-11 |
$235,703,000 |
| 10918645 |
Substituted tricyclic heterocyclic compounds and use thereof |
Edward Giles Mciver, Yang Song, Yuanyuan Xu, Lin Zhu, Chunjun Chu +3 more |
2021-02-16 |
|
| 10220096 |
Injectable and stable hydrogels with dynamic properties modulated by biocompatible catalysts |
Junzhe Lou, Ovijit Chaudhuri |
2019-03-05 |
|
| 9708443 |
Efficient synthesis of rigid ladder polymers |
Sheng Liu |
2017-07-18 |
|
| 9062007 |
Cyclic amide BACE-1 inhibitors having a benzamide substituent |
Jared N. Cumming, Ulrich Iserloh, Andrew Stamford, Corey Strickland, Johannes H. Voight +9 more |
2015-06-23 |
$67,157,000 |
| 9059413 |
Blue fluorescent organic material and organic light emitting diode panel thereof |
Xu Zhu, Liping Wang, Yi-Fan Wang, Qinghua Zou |
2015-06-16 |
|
| 8987242 |
Morpholinone compounds as factor IXA inhibitors |
Samuel Chackalamannil, Tin-Yau Chan, Mariappan V. Chelliah, Martin C. Clasby, Michael P. Dwyer +6 more |
2015-03-24 |
$65,013,000 |
| 8987195 |
HCV NS3 protease inhibitors |
Thomas Bara, Sathesh Bhat, Dipshikha Biswas, Linda Brockunier, Duane A. Burnett +17 more |
2015-03-24 |
$65,013,000 |
| 8907095 |
Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119 |
Craig D. Boyle, William J. Greenlee, Samuel Chackalamannil, Charles Lee Jayne |
2014-12-09 |
$45,770,000 |
| 8722882 |
Pyrimidine derivatives as GPCR modulators for use in the treatment of obesity and diabetes |
Bernard R. Neustadt, Andrew Stamford, Jinsong Hao, Charles Lee Jayne |
2014-05-13 |
$117,499,000 |
| 8642582 |
Morpholinone compounds as factor IXa inhibitors |
Hidemitsu Nishida, Fumihiko Saitoh, Tomokazu Hirabayashi, Samuel Chackalamannil, Tin-Yau Chan +4 more |
2014-02-04 |
$91,639,000 |
| 8623867 |
Cyclic amine BACE-1 inhibitors having a benzamide substituent |
Jared N. Cumming, Ulrich Iserloh, Andrew Stamford, Corey Strickland, Johannes H. Voight +9 more |
2014-01-07 |
$63,301,000 |
| 8609676 |
4, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitors |
Mariappan V. Chelliah, Samuel Chackalamannil, William J. Greenlee, Keith Eagan, Zhuyan Guo +6 more |
2013-12-17 |
$54,459,000 |
| RE44205 |
Adenosine A2a receptor antagonists |
Bernard R. Neustadt, Neil A. Lindo, William J. Greenlee, Deen Tulshian, Lisa S. Silverman +2 more |
2013-05-07 |
|
| 8278334 |
Cyclic amine BACE-1 inhibitors having a benzamide substituent |
Jared N. Cumming, Ulrich Iserloh, Andrew Stamford, Corey Strickland, Johannes H. Voigt +9 more |
2012-10-02 |
$45,103,000 |
| 8153664 |
Bicyclic and tricyclic derivatives as thrombin receptor antagonists |
Samuel Chackalamannil, Mariappan V. Chelliah, Yuguang Wang |
2012-04-10 |
|
| 8148363 |
Heterocyclic compounds as factor IXA inhibitors |
Martin C. Clasby, William J. Greenlee, Tin-Yau Chan, Mariappan V. Chelliah, Samuel Chackalamannil +6 more |
2012-04-03 |
|
| 8022088 |
Substituted bicyclic and tricyclic thrombin receptor antagonists |
Mariappan V. Chelliah, Samuel Chackalamannil |
2011-09-20 |
|
| 8003803 |
Fused ring thrombin receptor antagonists |
Samuel Chackalamannil |
2011-08-23 |
|
| 7897601 |
Cannabinoid receptor modulators |
Samuel Chackalamannil, Mariappan V. Chelliah, Martin C. Clasby, Keith Eagen, Jack D. Scott +2 more |
2011-03-01 |
|
| 7888377 |
Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists |
Mariappan V. Chelliah, Samuel Chackalamannil |
2011-02-15 |
|
| 7776889 |
Spirocyclic thrombin receptor antagonists |
Samuel Chackalamannil, Mariappan V. Chelliah |
2010-08-17 |
|
